clomipramine has been researched along with Obesity in 5 studies
Clomipramine: A tricyclic antidepressant similar to IMIPRAMINE that selectively inhibits the uptake of serotonin in the brain. It is readily absorbed from the gastrointestinal tract and demethylated in the liver to form its primary active metabolite, desmethylclomipramine.
clomipramine : A dibenzoazepine that is 10,11-dihydro-5H-dibenzo[b,f]azepine which is substituted by chlorine at position 3 and in which the hydrogen attached to the nitrogen is replaced by a 3-(dimethylamino)propyl group. One of the more sedating tricyclic antidepressants, it is used as the hydrochloride salt for the treatment of depression as well as obsessive-compulsive disorder and phobias.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| " We studied the effect of acute stimulation of the corticotropic axis on plasma leptin, the ob gene product, in 7 women of normal weight and 12 women with obesity." | 5.08 | Plasma leptin and acute serotoninergic stimulation of the corticotropic axis in women who are normal weight or obese. ( Basdevant, A; Guy-Grand, B; Laferrère, B; Lahlou, N; Oppert, JM; Roger, M, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maina, G | 1 |
| Albert, U | 1 |
| Salvi, V | 1 |
| Bogetto, F | 1 |
| Laferrère, B | 2 |
| Lahlou, N | 2 |
| Saltiel, H | 1 |
| Roger, M | 2 |
| Basdevant, A | 2 |
| Oppert, JM | 2 |
| Guy-Grand, B | 2 |
| Joseph, MG | 1 |
| Jouanny, AC | 1 |
| Chomienne, F | 1 |
| Champion, G | 1 |
| Giniès, JL | 1 |
| Limal, JM | 1 |
| Gurewitz, R | 1 |
| Blum, I | 1 |
| Lavie, P | 1 |
| Pertzelan, A | 1 |
| Stivel, M | 1 |
| Weinstein, R | 1 |
| Galatzer, A | 1 |
| Laron, Z | 1 |
1 review available for clomipramine and Obesity
| Article | Year |
|---|---|
[Hypothalamic syndromes. Review of clinical and endocrinal semiology].
Topics: Child, Preschool; Clomipramine; Disorders of Excessive Somnolence; Female; Follow-Up Studies; Gonado | 1993 |
3 trials available for clomipramine and Obesity
| Article | Year |
|---|---|
Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.
Topics: Adult; Ambulatory Care; Citalopram; Clomipramine; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies | 2004 |
Hypersensitivity of the corticotropic axis to the serotoninergic agent clomipramine in obese women.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Area Under Curve; Clomipramine; Diet, Reducing; Doub | 1994 |
Plasma leptin and acute serotoninergic stimulation of the corticotropic axis in women who are normal weight or obese.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Body Mass Index; Clomipramine; Double-Blind Method; | 1997 |
1 other study available for clomipramine and Obesity
| Article | Year |
|---|---|
Recurrent hypothermia, hypersomnolence, central sleep apnea, hypodipsia, hypernatremia, hypothyroidism, hyperprolactinemia and growth hormone deficiency in a boy--treatment with clomipramine.
Topics: Child, Preschool; Clomipramine; Disorders of Excessive Somnolence; Drinking; Growth Hormone; Humans; | 1986 |